Clinical Trials Directory

Trials / Completed

CompletedNCT00108355

Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis

Vasoconstrictors as Alternatives to Albumin After Large Volume Paracentesis in Cirrhosis

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
29 (actual)
Sponsor
US Department of Veterans Affairs · Federal
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This clinical trial compares a combination of two drugs that constrict blood vessels (Octreotide LAR and Midodrine) to albumin after large volume paracentesis. Subjects have cirrhosis and ascites.

Detailed description

This prospective, placebo-controlled, randomized, clinical trial compares the effect of a combination of vasoconstrictors (octreotide plus midodrine) to albumin on the time to recurrence of ascites in patients with refractory ascites treated with large volume paracentesis. The treatment allocation ratio for the two treatment arms is 1:1 using a stratified random permuted block design. Subjects are patients 18-80 years old with cirrhosis and ascites who are stratified according to the presence or absence of renal dysfunction at the time of randomization. Measurements include blood pressure, weight, girth, abdominal ultrasound, forearm blood flow, plasma renin activity, angiotensin, and aldosterone, repeated during a 6 month period.

Conditions

Interventions

TypeNameDescription
DRUGAlbuminIntravenous Albumin at a dose of 8g/liter of ascitic fluid removed
DRUGIntravenous Saline Infusion (Albumin placebo)Intravenous saline Infusion (Albumin placebo)
DRUGMidodrineMidodrine oral tablet at 10 mg three times a day.
DRUGOral tablet (Midodrine placebo)Oral tablet (Midodrine placebo) three times a day
DRUGOctreotide LAROctreotide LAR 20 mg intramuscular injection every 30 days
DRUGSaline injection (Octreotide LAR placebo)Saline intramuscular injection 5 cc every 30 days.
PROCEDURELarge Volume ParacentesisProcedure to remove large amounts (more than 5 liter) of ascitic fluid via a catheter.

Timeline

Start date
2003-12-01
Primary completion
2010-08-01
Completion
2012-08-01
First posted
2005-04-15
Last updated
2014-03-06
Results posted
2014-03-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00108355. Inclusion in this directory is not an endorsement.